세계의 나노포어 기술 시장 보고서 : 제품, 용도, 최종사용자, 지역별(2024-2032년)

The global nanopore technologies market size reached US$ 276.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 753.6 Million by 2032, exhibiting a growth rate (CAGR) of 11.4% during 2024-2032.

Nanopore technology refers to the next-generation molecule sequencing of single-molecule deoxyribonucleic acid (DNA) without the need for polymerase chain reaction (PCR) amplification and chemical labeling of the sample. It offers a relatively high throughput and low-cost genotyping, high mobility for testing, rapid processing of samples in real-time, and label-free, ultralong reads. It is used as a diagnostic tool to provide a fast analysis, eliminate cumbersome amplification and conversion steps, and detect target molecules at very low concentrations and screen panels of biomarkers or genes. Nowadays, the read quality of nanopore technology has improved significantly on account of the introduction of advanced nanopore proteins and chemistries.

Nanopore Technologies Market Trends:

The outbreak of the coronavirus disease (COVID-19), in confluence with the urgent need to develop a potential treatment, represents one of the key factors driving the need for nanopore technologies worldwide. Researchers are extensively relying on these technologies to generate data, ranging from initial characterization of the virus genome to the rapid identification of variants, essential to combating the spread of the pandemic. Apart from this, the increasing prevalence of cancer among a significant part of the population due to the rising number of individuals who smoke, drink, and have obesity and chronic inflammation is contributing to the market growth. Nanopore technologies are used in oncology settings for facilitating cancer diagnosis and treatment through the detection and accurate quantification of microRNA. In addition, leading market players are introducing a new generation of sensing technology that uses nanopores embedded in high-tech electronics to perform precise molecular analyses. This technology is gaining widespread adoption in applied settings, such as clinical diagnostics, epidemiology, food safety, agriculture, and environmental science. Such innovations are projected to influence the market positively.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global nanopore technologies market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end user.

Breakup by Product:

• Instruments
  • Portable
  • Benchtop
• Consumables

Breakup by Application:

• DNA Sequencing
• RNA Sequencing
• Others

Breakup by End User:

• Hospitals and Clinics
• Research Institutes
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Cyclomics BV, Electronic Biosciences Inc., Inanobio Inc., Nabsys Inc., Ontera Inc., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., Quantapore Inc., Roche Holding AG and Tracxn Technologies Limited.

Key Questions Answered in This Report

• 1. How big is the global nanopore technologies market?
• 2. What is the expected growth rate of the global nanopore technologies market during 2024-2032?
• 3. What are the key factors driving the global nanopore technologies market?
• 4. What has been the impact of COVID-19 on the global nanopore technologies market?
• 5. What is the breakup of the global nanopore technologies market based on the product?
• 6. What is the breakup of the global nanopore technologies market based on the application?
• 7. What is the breakup of the global nanopore technologies market based on the end user?
• 8. What are the key regions in the global nanopore technologies market?
• 9. Who are the key players/companies in the global nanopore technologies market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Nanopore Technologies Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Instruments
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Portable
    • 6.1.2.2 Benchtop
  • 6.1.3 Market Forecast
• 6.2 Consumables
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Application

• 7.1 DNA Sequencing
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 RNA Sequencing
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals and Clinics
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Research Institutes
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Agilent Technologies Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Cyclomics BV
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Electronic Biosciences Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Inanobio Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Nabsys Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Ontera Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Oxford Nanopore Technologies Limited
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 SWOT Analysis
  • 14.3.8 Pacific Biosciences of California Inc.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
  • 14.3.9 Quantapore Inc.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Roche Holding AG
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
  • 14.3.11 Tracxn Technologies Limited
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio